Using response surfaces to expand the utility of MAC.
Short
Timothy G
TG
D000762:Anesthesia Recovery Period; D019162:Anesthetics, Combined / Q000008:administration & dosage / Q000493:pharmacokinetics*; D018685:Anesthetics, Inhalation / Q000008:administration & dosage / Q000493:pharmacokinetics*; D018686:Anesthetics, Intravenous / Q000008:administration & dosage / Q000493:pharmacokinetics*; D003198:Computer Simulation; D003243:Consciousness / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004867:Equipment Design; D005283:Fentanyl / Q000493:pharmacokinetics; D006801:Humans; D007530:Isoflurane / Q000493:pharmacokinetics; D008738:Methyl Ethers / Q000493:pharmacokinetics; D008954:Models, Biological; D016343:Monitoring, Intraoperative / Q000295:instrumentation; D017288:Pain Threshold / Q000187:drug effects; D010880:Piperidines / Q000493:pharmacokinetics; D011237:Predictive Value of Tests; D011650:Pulmonary Alveoli / Q000378:metabolism*; D020127:Recovery of Function; D000077208:Remifentanil; D000077149:Sevoflurane
D019162:Anesthetics, Combined; D018685:Anesthetics, Inhalation; D018686:Anesthetics, Intravenous; D008738:Methyl Ethers; D010880:Piperidines; D000077149:Sevoflurane; D007530:Isoflurane; D000077208:Remifentanil; D005283:Fentanyl